top of page
Rohit Kohli

Rohit Kohli

MD, MS, FAASLD. NASPGHAN-F
2022 Healthcare Visionary Honoree

Chief, Division of Gastroenterology, Hepatology and Nutrition,
Director, The George Donnell Society for Pediatric Scientists,
Associates Endowed Chair in Liver and Intestinal Research at Children's Hospital Los Angeles,
Professor of Pediatrics (Clinical Scholar), Keck School of Medicine, at University of Southern California.

It is with great pleasure that Liver Health Foundation salutes Dr. Rohit Kohli as the 2022 Healthcare Visionary for his exceptional service to our community and liver patients. Please join us as we present Dr. Kohli with his award on September 30th at “Salute to Excellence Dinner Gala.”

Dr. Kohli’s accomplishments Have been extraordinary. Through his efforts countless lives have been saved. We at Liver Health Foundation have witnessed the exceptional compassion and tenderness Dr. Kohli offers young patients, making life easier for so many every day.

We salute Dr. Kohli for his tireless and continuous research on the unfortunate disease of our time, non-alcoholic fatty liver disease, NAFLD, and its extreme stage, NASH. The healthcare Visionary Award Will be presented annually to a truly exceptional physician in our community. We cannot think of anyone that exemplifies effective, patient-centered, and compassionate leadership more than our honoree.

Dr. Kohli received his medical degree from the Armed Forces Medical College, India in 1999 and his MS in Clinical Investigation from Northwestern University in 2006. While at Northwestern, Dr. Kohli first spent three years as a pediatric gastroenterology and hepatology fellow and then subsequently as a transplant hepatology trainee before relocating to University of Cincinnati in 2007.

His research work has focused on the pathogenesis of obesity related fatty liver disease (NAFLD). Dr. Kohli has focused upon the role of bile acid signaling as a mechanism for NAFLD resolution after weight loss surgery. His work has also shed light on reactive oxygen stress in the generation and regulation of the extreme stage of this disease; nonalcoholic Steatohepatitis (NASH). He has published many peer-reviewed articles including articles in Nature, Nature Review, the Journal of Biological Chemistry, Hepatology, Journal of Pediatrics, and the American Journal of Physiology.

Dr. Kohli is the author of many book chapters and review articles. He is the recipient of the 2007 George Ferry Young Investigator Award from the Children’s Digestive Health and Nutrition Foundation, a Fellowship award from the American Association for the Study of Liver Diseases (AASLD), Takeda Research Innovation Award from the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Foundation. Dr. Kohli is a member of the American Pediatric Society and Liver Health Foundation’s Medical Advisory Council. We salute Dr. Kohli for his exemplary research work and compassionate treatment of pediatric liver disease patients.

bottom of page